T1	Participants 814 904	132 subjects, 124 (94%) were already receiving treatment with antihypertensive medications
T2	Participants 494 580	132 subjects in this randomized, controlled trial were in the age range of 40-79 years
T3	Participants 299 342	patients with mild to moderate hypertension
